Newamsterdam Pharma Co Nv (NAMS)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 480 |
| % of all portfolios: | 0.017% |
| Hold Price * : | $33.89 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
1 |
$226,500 |
| Sells |
9 |
$11,375,584 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 15 Sep 2026 |
DAVIDSON MICHAEL H. |
Chief Executive Officer |
14 Sep 2026 |
10,000 |
22.65 |
226,500 |
| 17 Sep 2025 |
TOPPER JAMES N |
Director |
15 Sep 2025 |
660 |
23.70 |
15,639 |
| 10 Sep 2025 |
TOPPER JAMES N |
Director |
08 Sep 2025 |
1,260 |
24.99 |
31,487 |
| 13 Aug 2025 |
TOPPER JAMES N |
Director |
11 Aug 2025 |
471 |
23.98 |
11,294 |
| 26 Jun 2025 |
TOPPER JAMES N |
Director |
25 Jun 2025 |
1,260 |
18.26 |
23,012 |
| 26 Jun 2025 |
TOPPER JAMES N |
Director |
24 Jun 2025 |
2,520 |
18.43 |
46,454 |
| 18 Jun 2025 |
TOPPER JAMES N |
Director |
16 Jun 2025 |
8,584 |
19.50 |
167,381 |
| 28 Mar 2025 |
TOPPER JAMES N |
Director |
26 Mar 2025 |
1,135 |
22.49 |
25,521 |
| 06 Mar 2025 |
TOPPER JAMES N |
Director |
04 Mar 2025 |
4,005 |
21.02 |
84,203 |
| 30 Sep 2024 |
AUDET JULIETTE BERANGERE |
Chief Business Officer |
26 Sep 2024 |
1,104 |
15.70 |
17,333 |
| 22 Aug 2024 |
DAVIDSON MICHAEL H. |
Chief Executive Officer |
20 Aug 2024 |
5,000 |
16.27 |
81,350 |
| 24 Jun 2024 |
DAVIDSON MICHAEL H. |
Chief Executive Officer |
20 Jun 2024 |
5,000 |
17.26 |
86,308 |
| 28 Mar 2024 |
TOPPER JAMES N |
Director |
26 Mar 2024 |
8,429 |
21.50 |
181,224 |
| 21 Feb 2024 |
LANGE LOUIS G |
Director |
13 Feb 2024 |
5,000 |
19.00 |
95,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock